Presence of secretory group IIa and V phospholipase A2 and cystosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 6, 2004, Pages 602-610

  Leistad, Lilian ^a   Feuerherm, Astrid J ^a,b   Østensen, Monika ^c   Faxvaag, Arild ^a   Johansen, Berit ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cartilage; Immunohistochemistry; Phospholipases A2; Reverse transcriptase polymerase chain reaction; Rheumatoid arthritis

Indexed keywords

ISOENZYME; MESSENGER RNA; PHOSPHOLIPASE A2;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; RNA ANALYSIS; SECRETORY GRANULE; STAINING; TISSUE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BONE MATRIX; CARTILAGE, ARTICULAR; CHONDROCYTES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOARTHRITIS; PHOSPHOLIPASES A; RNA, MESSENGER; STAINING AND LABELING;

ANIMALIA;

EID: 3242764656     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.104     Document Type: Article

References (55)

1. Harris ED. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990; 322:1277-89.
2. Panayi GS. The immunopathogenesis of rheumatoid arthritis. Rheumatology Rev 1994;10:305-7.
3. Klippel JH, Dieppe PA, editors. Bullough PG. Osteoarthritis: pathology. Rheumatology. London: Mosby-Year Book Europe Limited, 1994:7.1-7.8.
4. Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I, et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998;12:2165-74.
5. Kim KW, Rafter JD, Bittova L, Han SK, Snitko Y, Munoz NM, et al. Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation. J Biol Chem 2001;276:11126-34.
6. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I. Regulatory functions of phospholipase A2. Crit Rev Immunol 1997;17:225-83.
7. Andersen SB. Expressional and functional analyses of human secretory phospholipase A2 [thesis]. Trondheim: Norwegian University of Science and Technology 1999:168pp.
8. Dennis EA. Diversity of group types, regulation and function of phospholipase A2. J Biol Chem 1994; 269:13057-60.
9. Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 2000;1488:1-19.
10. Kim YJ, Kim KP, Han SK, Munoz NM, Zhu X, Sano H, et al. Group V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IV phospholipase A2. Biol Chem 2002; 277:36479-88.
11. Murakami M, Koduri RS, Enomoto A, Shimbara S, Seki M, Yoshihara K, et al. Distinct arachidonate-releasing function of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanism. J Biol Chem 2001;276:10083-96.
12. Kudo I, Murakami M, Hara S, Inoue K. Mammalian nonpancreatic phospholipases A2. Biochim Biophys Acta 1993;1170:217-31.
13. Andersen S, Sjursen W, Lægreid A, Volden G, Johansen, B. Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue. Inflammation 1994;18:1-12.
14. Chen Y, Dennis EA. Expression and characterization of human group V phospholipase A2. Biochim Biophys Acta 1998;1394:57-64.
15. Degousee N, Ghomashchi F, Stefanski E, Singer A, Smart BP, Borregaard N. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and Gram-negative bacterial phospholipid hydrolysis. J Biol Chem 2002;277:5061-73.
16. Wolbink GJ, Bossink AW, Groeneveld AB, de Groot MC, Thijs LG, Hack CE. Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis 1998;177:81-7.
17. Green JA, Smith GM, Buchta R, Lee R, Ho KY, Rajkovic IA, et al. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation 1991;15:355-67.
18. Vadas P, Keystone J, Stefanski E, Scott K, Pruzanski W. Induction of circulating group II phospholipase A2 expression in adults with malaria. Infect Immun 1992;60:3928-31.
19. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 1996;87:2573-8.
20. Aarsman AJ, Neys FW, van der Helm HA, Kuypers FA, van den Bosch H. Sera of patients suffering from inflammatory diseases contain group IIA but not group V phospholipases A2. Biochim Biophys Acta 2000;1502:257-63.
21. Vadas P, Stefanski E, Pruzanski W. Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid. Life Sci 1985;36:579-87.
22. Lin MK, Farewell V, Vadas P, Bookman AA, Keystone EC, Pruzanski WJ. Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. Rheumatol 1996;23:1162-6.
23. Smith GM, Ward RL, McGuigan L, Rajkovic IA, Scott KF. Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol 1992;31:175-8.
24. Vadas P, Browning J, Edelson J, Pruzanski W. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat 1993;8:1-30.
25. Pruzanski W, Vadas P, Stefanski E, Urowitz MB. Phopholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J Rheumatol 1985;12:211-6.
26. Pruzanski W, Vadas P, Kim J, Jacobs H, Stefanski E. Phospholipase A2 activity associated with synovial fluid cells. J Rheumatol 1988;15:791-4.
27. Kramer RM, Hession C, Johansen B, Hayes G, McGray P, Chow EP, et al. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 1989;264:5768-75.
28. Pruzanski W, Bogoch E, Stefanski E, Wloch M, Vadas P. Synthesis and release of phospholipase A2 by unstimulated human articular chondrocytes. J Rheumatol 1990;17:1386-91.
29. Pruzanski W, Bogoch E, Katz A, Wloch M, Stefanski E, Grouix B, et al. Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes. J Rheumatol 1995;22:2114-9.
30. Pruzanski W, Bogoch E, Stefanski E, Wloch M, Vadas P. Enzymatic activity and distribution of phospholipase A2 in human cartilage. Life Sci 1991;48:2457-62.
31. Clark JD, Schievella AR, Nalefski EA, Lin LL. Cytosolic phospholipase A2. J Lipid Mediat Cell Signal 1995; 12:83-117.
32. Sharp JD, White DL. Cytosolic PLA2: mRNA levels and potential for transcriptional regulation. J Lipid Mediat 1993;8:183-9.
33. Habtemariam A, Grönblad M, Virri J, Airaksinen O, Luukkonen M, Turunen V, et al. Comparative immunohistochemical study of group IIA (synovial-type) and group IV (cytosolic) phospholipase A2 in disc prolapse tissue. Eur Spine 1998;7:387-93.
34. Pruzanski W, Vadas P. Phospholipase A2 - a mediator between proximal and distal effectors of inflammation. Immunol Today 1991;12:143-6.
35. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in pathogenesis of rheumatoid arthritis. J Clin Invest 2002;110:651-8.
36. Nakamura H, Hishinuma T, Suzuki N, Chiba S, Tsukamoto H, Takabatake M, et al. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. Prostaglandins Leukot Essent Fatty Acids 2001;65:301-6.
37. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
38. Johansen B, Kramer RM, Hession C, McGray P, Pepinsky RB. Expression, purification and biochemical comparison of natural and recombinant human nonpancreatic phospholipase A2. Biochem Biophys Res Commun 1992;187:544-51.
39. Hurt-Camejo E, Andersen S, Standal R, Rosengren B, Sartipy P, Stadberg E, et al. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler Thromb Vasc Biol 1997;17:300-9.
40. Anthonsen MW, Stengel D, Hourton D, Ninio E. Johansen B. Mildly oxidized LDL induces expression of group IIA secretory phospholipase A2 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 2000;20:1276-82.
41. Leistad L, Østensen M, Faxvaag A. Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase-polymerase chain reaction. Scand J Rheumatol 1998;27:61-7.
42. Clark JD, Milona N, Knopf JL. Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci USA 1990;87:7708-12.
43. Kramer RM, Roberts EF, Manetta J, Putnam JE. The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem 1991;266:5268-72.
44. Balsinde J, Barbour SE, Bianco ID, Dennis EA. Arachidonic acid mobilization in p388 d1 macrophages is controlled by two distinct cCa2+-dependent phospholipase A2 enzymes. Proc Natl Acad Sci USA 1994;91:11060-4.
45. de Carvalho MGS, Garritano J, Leslie CC. Regulation of lysophospholipase activity of the 85-kDa phospholipase A2 and activation in mouse peritoneal macrophages. J Biol Chem 1995;270:20439-46.
46. Gijòn MA, Leslie CC. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J Leukoc Biol 1999;65:330-6.
47. Lum H. Lysophospholipids in the regulation of endothelial barrier function. Am J Physiol Lung Cell Mol Phyiol 2001;281:1335-6.
48. Scott KF, Bryant KJ, Bidgood MJ. Functional coupling and differential regulation on the phospholipase A2-cyclooxygenase pathways in inflammation. J Leukoc Biol 1999;535-41.
49. Chen J, Engle SJ, Seilhamer JJ, Tischfield JA. Cloning and recombinant expression of a novel human low molecular weight Ca(2 +)-dependent phopholipase A2. J Biol Chem 1994;269:2365-8.
50. Tischfield JA. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J Biol Chem 1997;272:17247-50.
51. Friess H, Shrikhande S, Riesle E, Kashiwagi M, Baczako K, Zimmermann A, et al. Phospholipase A2 isoforms in acute pancreatitis. Ann Surg 2001;233:204-12.
52. Miwa M, Saura R, Hirata S, Hayashi Y, Mizuno K, Itoh H. Induction of apoptosis in bovine articular chondrocyte by prostaglandin E2 through cAMP-dependent pathway. Osteoarthritis Cartilage 2000;8:17-24.
53. 1 macrophages. J Biol Chem 1996;271:6758-65.
54. Fonteh AN, Atsumi G, LaPorte T, Chilton FH. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. J Immunol 2000;165:2773-82.
55. Antonsen MW, Solhaug A, Johansen B. Functional coupling between secretory and cytosolic phospholipase A2 modulates TNF-α and IL1β-induced NF-κB activation. J Biol Chem 2001; 276:30527-36.